{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T19:22:03Z","timestamp":1774725723163,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"am","delay-in-days":272,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI140287-05"],"award-info":[{"award-number":["R01AI140287-05"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers &amp; Chemical Engineering"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.compchemeng.2024.108884","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T16:30:28Z","timestamp":1727195428000},"page":"108884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Rapid design of combination antimicrobial therapy against Acinetobacter baumannii"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9920-7719","authenticated-orcid":false,"given":"Brianna M.","family":"Eales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazanin","family":"Pouya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole S.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-5376","authenticated-orcid":false,"given":"Vincent H.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0241-6600","authenticated-orcid":false,"given":"Michael","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.compchemeng.2024.108884_bib0001","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10096-007-0371-8","article-title":"Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes","volume":"26","author":"Abbo","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.compchemeng.2024.108884_bib0002","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4103\/1817-1737.164302","article-title":"Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia","volume":"10","author":"Al-Dorzi","year":"2015","journal-title":"Ann. Thorac. Med."},{"issue":"11","key":"10.1016\/j.compchemeng.2024.108884_bib0003","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/aic.690451110","article-title":"Entry mass transfer in axial flows through randomly packed fiber bundles","volume":"45","author":"Bao","year":"1999","journal-title":"AIChe J."},{"issue":"8","key":"10.1016\/j.compchemeng.2024.108884_bib0004","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/aic.14882","article-title":"Modeling heterogeneous bacterial populations exposed to antibiotics: the logistic-dynamics case","volume":"61","author":"Bhagunde","year":"2015","journal-title":"AIChe J."},{"key":"10.1016\/j.compchemeng.2024.108884_bib0005","doi-asserted-by":"crossref","DOI":"10.4172\/1989-8436-C1-001","article-title":"The hollow fiber infection model: principles and practice","volume":"08","author":"Cadwell","year":"2017","journal-title":"Arch. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.compchemeng.2024.108884_bib0006","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4155\/bio-2020-0007","article-title":"A robust LC-MS\/MS method for amikacin: application to cellular uptake and pharmacokinetic studies","volume":"12","author":"Chan","year":"2020","journal-title":"Bioanalysis."},{"key":"#cr-split#-10.1016\/j.compchemeng.2024.108884_bib0007.1","doi-asserted-by":"crossref","unstructured":"7Craig W.A. Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1998;26(1):1-10","DOI":"10.1086\/516284"},{"key":"#cr-split#-10.1016\/j.compchemeng.2024.108884_bib0007.2","doi-asserted-by":"crossref","unstructured":"quiz 1-2. Epub 1998\/02\/10. doi: 10.1086\/516284. PubMed PMID: 9455502.","DOI":"10.1086\/516284"},{"key":"10.1016\/j.compchemeng.2024.108884_bib0008","author":"D'Argenio","year":"2009","journal-title":"ADAPT 5 User's Guide: Pharmacokinetic\/Pharmacodynamic Systems Analysis Software"},{"issue":"13","key":"10.1016\/j.compchemeng.2024.108884_bib0009","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.biomaterials.2009.01.011","article-title":"Human hepatocyte functions in a crossed hollow fiber membrane bioreactor","volume":"30","author":"De Bartolo","year":"2009","journal-title":"J. Biomater."},{"key":"10.1016\/j.compchemeng.2024.108884_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(02)00223-1","article-title":"Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models","volume":"95","author":"Giraldo","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.compchemeng.2024.108884_bib0011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(02)00223-1","article-title":"Assessing the (a) symmetry of concentration-effect curves: empirical versus mechanistic models","volume":"95","author":"Giraldo","year":"2002","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.compchemeng.2024.108884_bib0012","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/j.1875-9114.2012.01137.x","article-title":"Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs","volume":"32","author":"Goff","year":"2012","journal-title":"Pharmacotherapy."},{"issue":"3","key":"10.1016\/j.compchemeng.2024.108884_bib0013","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/viru.19700","article-title":"Acinetobacter baumannii: an emerging opportunistic pathogen","volume":"3","author":"Howard","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.compchemeng.2024.108884_bib0014","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jps.2600600618","article-title":"Pharmacodynamics of chemotherapeutic effects: dose-time-response relationships for phase-nonspecific agents","volume":"60","author":"Jusko","year":"1971","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.compchemeng.2024.108884_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2022.107212","article-title":"Deciphering longitudinal optical-density measurements to guide clinical dosing regimen design: a model-based approach","volume":"227","author":"Kesisoglou","year":"2022","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.compchemeng.2024.108884_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.compchemeng.2021.107617","article-title":"Discerning in vitro pharmacodynamics from OD measurements: a model-based approach","volume":"158","author":"Kesisoglou","year":"2022","journal-title":"Comput. Chem. Eng."},{"issue":"2","key":"10.1016\/j.compchemeng.2024.108884_bib0017","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/AAC.41.2.363","article-title":"The Population Dynamics of Antimicrobial Chemotherapy","volume":"41","author":"Lipsitch","year":"1997","journal-title":"Antimicrob. Agents Chemother"},{"issue":"8","key":"10.1016\/j.compchemeng.2024.108884_bib0018","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s10439-007-9306-x","article-title":"Modeling of Microbial Population Responses to Time-Periodic Concentrations of Antimicrobial Agents","volume":"35","author":"Nikolaou","year":"2007","journal-title":"Ann. Biomed. Eng."},{"issue":"2","key":"10.1016\/j.compchemeng.2024.108884_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00285-005-0350-6","article-title":"A New Modeling Approach to the Effect of Antimicrobial Agents on Heterogeneous Microbial Populations","volume":"52","author":"Nikolaou","year":"2006","journal-title":"J. Math. Biol."},{"issue":"6","key":"10.1016\/j.compchemeng.2024.108884_bib0020","article-title":"Rapid In Vitro Assessment of Antimicrobial Drug Effect Bridging Clinically Relevant Pharmacokinetics: a Comprehensive Methodology","volume":"15","author":"Nikolaou","year":"2023","journal-title":"Pharmaceutics [Internet]"},{"issue":"7","key":"10.1016\/j.compchemeng.2024.108884_bib0021","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/AAC.01430-08","article-title":"Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units","volume":"53","author":"Oliveira","year":"2009","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.compchemeng.2024.108884_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00158","article-title":"Motsinger-Reif AA. An Introduction to Terminology and Methodology of Chemical Synergy\u2014Perspectives from Across Disciplines","volume":"8","author":"Roell","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"63","key":"10.1016\/j.compchemeng.2024.108884_bib0023","first-page":"e3064","article-title":"Aseptic Laboratory Techniques: plating Methods","author":"Sanders","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.compchemeng.2024.108884_bib0024","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3201\/eid1301.060716","article-title":"Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization","volume":"13","author":"Sunenshine","year":"2007","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.compchemeng.2024.108884_bib0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jac\/dkaa412","article-title":"Optimizing pharmacokinetics\/pharmacodynamics of beta-lactam\/beta-lactamase inhibitor combinations against high inocula of ESBL-producing bacteria","volume":"76","author":"Tam","year":"2021","journal-title":"J. Antimicrob. Chemother"},{"issue":"5","key":"10.1016\/j.compchemeng.2024.108884_bib0026","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/jac\/dkx001","article-title":"Determining beta-lactam exposure threshold to suppress resistance development in Gram-negative bacteria","volume":"72","author":"Tam","year":"2017","journal-title":"J. Antimicrob. Chemother"},{"issue":"12","key":"10.1016\/j.compchemeng.2024.108884_bib0027","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/518003","article-title":"Impact of Drug-Exposure Intensity and Duration of Therapy on the Emergence of Staphylococcus aureus Resistance to a Quinolone Antimicrobial","volume":"195","author":"Tam","year":"2007","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/j.compchemeng.2024.108884_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1001043","article-title":"A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design","volume":"7","author":"Tam","year":"2011","journal-title":"PLoS Comput. Biol."},{"issue":"5","key":"10.1016\/j.compchemeng.2024.108884_bib0029","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-3476(86)80754-5","article-title":"Kinetics of antimicrobial activity","volume":"108","author":"Vogelman","year":"1986","journal-title":"J. Pediatr."},{"issue":"7643","key":"10.1016\/j.compchemeng.2024.108884_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nature.2017.21550","article-title":"The drug-resistant bacteria that pose the greatest health threats","volume":"543","author":"Willyard","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.compchemeng.2024.108884_bib0031","series-title":"Mathematica, Version 13.1","year":"2022"},{"key":"10.1016\/j.compchemeng.2024.108884_bib0032","series-title":"Global Antimicrobial Resistance and Use Surveillance System (GLASS) report: 2022","first-page":"2022","year":"2022"}],"container-title":["Computers &amp; Chemical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098135424003028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098135424003028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T03:02:23Z","timestamp":1732244543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098135424003028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"alternative-id":["S0098135424003028"],"URL":"https:\/\/doi.org\/10.1016\/j.compchemeng.2024.108884","relation":{},"ISSN":["0098-1354"],"issn-type":[{"value":"0098-1354","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid design of combination antimicrobial therapy against Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"Computers & Chemical Engineering","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compchemeng.2024.108884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108884"}}